GenSight Biologics S.A. (FRA:G49N)

GenSight Biologics Revenue

GenSight Biologics had revenue of 48.00K EUR in the half year ending June 30, 2025, a decrease of -98.23%. This brings the company's revenue in the last twelve months to 945.00K, down -52.18% year-over-year. In the year 2024, GenSight Biologics had annual revenue of 2.63M, down -11.44%.

• Revenue (ttm): 945.00K
• Revenue Growth: -52.18%
• P/S Ratio: 18.41
• Revenue / Employee: 72.69K
• Employees: 13
• Market Cap: 17.40M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.63M	-339.00K	-11.44%
Dec 31, 2023	2.96M	-1.90M	-39.08%
Dec 31, 2022	4.87M	-2.84M	-36.89%
Dec 31, 2021	7.71M	269.00K	3.62%
Dec 31, 2020	7.44M	2.53M	51.53%